Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC).
Ryan CJ, Dutta S, Kelly WK, Russell C, Small EJ, Morris MJ, Taplin ME, Halabi S; From The Alliance for Clinical Trials in Oncology Genitourinary Committee. Ryan CJ, et al. Among authors: dutta s. Prostate Cancer Prostatic Dis. 2020 Mar;23(1):66-73. doi: 10.1038/s41391-019-0152-3. Epub 2019 May 3. Prostate Cancer Prostatic Dis. 2020. PMID: 31053766 Free PMC article.
Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer.
Halabi S, Dutta S, Tangen CM, Rosenthal M, Petrylak DP, Thompson IM Jr, Chi KN, De Bono JS, Araujo JC, Logothetis C, Eisenberger MA, Quinn DI, Fizazi K, Morris MJ, Higano CS, Tannock IF, Small EJ, Kelly WK. Halabi S, et al. Among authors: dutta s. Ann Oncol. 2020 Jul;31(7):930-941. doi: 10.1016/j.annonc.2020.03.309. Epub 2020 Apr 11. Ann Oncol. 2020. PMID: 32289380 Free PMC article.
Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel.
Halabi S, Dutta S, Tangen CM, Rosenthal M, Petrylak DP, Thompson IM Jr, Chi KN, Araujo JC, Logothetis C, Quinn DI, Fizazi K, Morris MJ, Eisenberger MA, George DJ, De Bono JS, Higano CS, Tannock IF, Small EJ, Kelly WK. Halabi S, et al. Among authors: dutta s. J Clin Oncol. 2019 Feb 10;37(5):403-410. doi: 10.1200/JCO.18.01279. Epub 2018 Dec 21. J Clin Oncol. 2019. PMID: 30576268 Free PMC article.
Androgens and Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Docetaxel.
Ryan CJ, Dutta S, Kelly WK, Middleberg R, Russell C, Morris MJ, Taplin ME, Halabi S; Alliance for Clinical Trials in Oncology Genitourinary Committee. Ryan CJ, et al. Among authors: dutta s. Clin Genitourin Cancer. 2020 Jun;18(3):222-229.e2. doi: 10.1016/j.clgc.2019.10.002. Epub 2019 Oct 17. Clin Genitourin Cancer. 2020. PMID: 32273234 Free PMC article. Clinical Trial.
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel.
Halabi S, Dutta S, Tangen CM, Rosenthal M, Petrylak DP, Thompson IM Jr, Chi KN, De Bono JS, Araujo JC, Logothetis C, Eisenberger MA, Quinn DI, Fizazi K, Morris MJ, Higano CS, Tannock IF, Small EJ, Kelly WK. Halabi S, et al. Among authors: dutta s. JNCI Cancer Spectr. 2020 Jan 29;4(2):pkaa003. doi: 10.1093/jncics/pkaa003. eCollection 2020 Apr. JNCI Cancer Spectr. 2020. PMID: 32368717 Free PMC article.
4,277 results